Published August 2, 2022
| Version v1
Patent
Open
Development of new monoclonal antibodies recognizing human prostate-specific membrane antigen (PSMA)
- 1. University of Chicago
- 2. University of Michigan
Contributors
Patent applicants:
Patent assignee:
Description
Provided herein are compositions and methods for the inhibition of enteric infection. In particular, compositions comprising bacteria of the class Clostridia are administered to human and/or animal subjects to prevent or decrease susceptibility to enteric infection.
Files
US11400121.pdf
Files
(2.0 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:e8156516b55c5f01c0471bead131e348
|
2.0 MB | Preview Download |
Additional details
Identifiers
- Patent number
- US 11400121 B2
- Patent application number
- US 201816476216 A
- Other
- oai:uchicago.tind.io:7397
Dates
- Patent filed
-
2018-01-05